SCP0064
cAMP Dependent PKI Peptide
≥95% (HPLC), lyophilized powder
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Empirical Formula (Hill Notation):
C85H149N31O24
Molecular Weight:
1989.29
UNSPSC Code:
12352202
NACRES:
NA.32
product name
cAMP Dependent Protein Kinase Inhibitor PKI-tide,
Assay
≥95% (HPLC)
form
lyophilized
composition
Peptide Content, ≥67%
storage condition
protect from light
storage temp.
−20°C
Amino Acid Sequence
Ile-Ala-Ala-Gly-Arg-Thr-Gly-Arg-Arg-Gln-Ala-Ile-His-Asp-Ile-Leu-Val-Ala-Ala
Application
IAAGRTGRRQAIHDILVAA is used as a cAMP-dependent protein kinase inhibitory peptide.
Biochem/physiol Actions
cAMP dependent protein kinase inhibitors are generally designed to target the synthesis and degradation of cAMP (cyclic adenosine monophophaphate), a second messenger.
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Barbara Wienen-Schmidt et al.
ChemMedChem, 16(1), 292-300 (2020-10-09)
In lead optimization, protein crystallography is an indispensable tool to analyze drug binding. Binding modes and non-covalent interaction inventories are essential to design follow-up synthesis candidates. Two protocols are commonly applied to produce protein-ligand complexes: cocrystallization and soaking. Because of
Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design
Taylor SS, et al.
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 1784(1), 16-26 (2008)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service